T. Rowe Price Associates

Activity from announced rounds

Activity in this selectionSeries C+
Rounds participated in
6
Confirmed lead rounds
—
6 roles undisclosed
New companies
6
First participation on record · 0 follow-on
Funding in participating rounds
$2.9B
6 disclosed · full round size, not this investor’s share

By stage

Series C+6

By primary sector

Biotech2
AI1
Defense tech1
Developer tools1
Space tech1

By country

United States5
Australia1

Rounds

6 in this selection
Castelion

Builds low-cost, mass-producible hypersonic strike missiles for defense

$1BSeries C
Role not disclosed
K2 Space

Manufactures large, high-power satellites.

$500MSeries D
Role not disclosed
AdvanCell

AdvanCell develops targeted alpha radiopharmaceuticals for cancer using Lead-212, with integrated isotope supply and manufacturing.

$315MSeries D
Role not disclosed
SambaNova

Provides next-generation AI infrastructure for enterprises, neo-clouds, and sovereign AI initiatives

$350MSeries E
Role not disclosed
ClickHouse

Provides real-time analytics, data warehousing, observability, and AI/ML infrastructure

$400MSeries D
Role not disclosed
Parabilis Medicines

Develops medicines targeting historically undruggable protein targets in cancer

$305MSeries F
Role not disclosed